Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0239 Transporter Info
Gene Name	SLC27A2
Transporter Name	Very long-chain acyl-CoA synthetase
Gene ID	11001
UniProt ID	O14975

Post-Translational Modification of This DT
Overview of SLC27A2 Modification Sites with Functional and Structural Information
Sequence	M L S A I Y T V L A G L L F L P L L V N L C C P Y F F Q D I G Y F L K V A A V G R R V R S Y G K R R P A R T I L R A F L E K A R Q T P H K P F L L F R D E T L T Y A Q V D R R S N Q V A R A L H D H L G L R Q G D C V A L L M G N E P A Y V W L W L G L V K L G C A M A C L N Y N I R A K S L L H C F Q C C G A K V L L V S P E L Q A A V E E I L P S L K K D D V S I Y Y V S R T S N T D G I D S F L D K V D E V S T E P I P E S W R S E V T F S T P A L Y I Y T S G T T G L P K A A M I T H Q R I W Y G T G L T F V S G L K A D D V I Y I T L P F Y H S A A L L I G I H G C I V A G A T L A L R T K F S A S Q F W D D C R K Y N V T V I Q Y I G E L L R Y L C N S P Q K P N D R D H K V R L A L G N G L R G D V W R Q F V K R F G D I C I Y E F Y A A T E G N I G F M N Y A R K V G A V G R V N Y L Q K K I I T Y D L I K Y D V E K D E P V R D E N G Y C V R V P K G E V G L L V C K I T Q L T P F N G Y A G A K A Q T E K K K L R D V F K K G D L Y F N S G D L L M V D H E N F I Y F H D R V G D T F R W K G E N V A T T E V A D T V G L V D F V Q E V N V Y G V H V P D H E G R I G M A S I K M K E N H E F D G K K L F Q H I A D Y L P S Y A R P R F L R I Q D T I E I T G T F K H R K M T L V E E G F N P A V I K D A L Y F L D D T A K M Y V P M T E D I Y N A I S A K T L K L
PTM type	X-Acetylation X-Neddylation X-O-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-S-sulfenylation X-Sulfoxidation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	291
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC27A2 Lysine 291 has the potential to affect its expression or activity.
Neddylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Neddylation at SLC27A2 Lysine 398 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[3]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	345
Experimental Method	Co-Immunoprecipitation
Detailed Description	Neddylation at SLC27A2 Valine 345 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	226
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC27A2 Serine 226 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	225
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC27A2 Threonine 225 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC27A2 Cystine 301 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	427
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC27A2 Cystine 427 has the potential to affect its expression or activity.
Phosphorylation
Serine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 171 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 252 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC27A2			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 293 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC27A2			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 295 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC27A2			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	322
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 322 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC27A2			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	552
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Serine 552 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	238
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 238 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	246
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 246 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC27A2			[9] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	249
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 249 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC27A2			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	564
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 564 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC27A2			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	568
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 568 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC27A2			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	570
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 570 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC27A2			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	577
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Threonine 577 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[14]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	244
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC27A2 Tyrosine 244 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[18]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC27A2 Cystine 301 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[19]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	22
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC27A2 Cystine 22 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[19]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC27A2 Cystine 23 has the potential to affect its expression or activity.
S-sulfenylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[20]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfenylation (-SOH) at SLC27A2 Cystine 320 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[21]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	576
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC27A2 Methionine 576 has the potential to affect its expression or activity.
Ubiquitination
Alanine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	336
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Alanine 336 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	547
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Alanine 547 has the potential to affect its expression or activity.
Asparticacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[23]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	395
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Asparticacid 395 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	563
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Asparticacid 563 has the potential to affect its expression or activity.
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[24]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Cystine 279 has the potential to affect its expression or activity.
Glutamicacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[22] , [25]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	366
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Glutamicacid 366 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	536
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Glutamicacid 536 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	522
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Glycine 522 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[24]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Leucine 272 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	337
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Leucine 337 has the potential to affect its expression or activity.
Lysine	17 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[3] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	173
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 173 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22] , [25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	174
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 174 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC27A2			[24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	325
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 325 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC27A2			[24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	332
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 332 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC27A2			[3] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	389
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 389 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	390
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 390 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC27A2			[3] , [25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 398 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC27A2			[22] , [23]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	403
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 403 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC27A2			[22] , [25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	419
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 419 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC27A2			[3] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	442
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 442 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC27A2			[23]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	447
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 447 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC27A2			[23]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	448
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 448 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	540
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 540 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	575
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 575 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	589
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 589 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	600
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 600 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	616
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Lysine 616 has the potential to affect its expression or activity.
Tryptophan	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[22]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Tryptophan 487 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[23]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	394
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Tyrosine 394 has the potential to affect its expression or activity.
Valine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC27A2			[3] , [25]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	345
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Valine 345 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC27A2			[22] , [23]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	350
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC27A2 Valine 350 has the potential to affect its expression or activity.

References
1	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
2	Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
3	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
4	Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018 Apr;17(4):764-775.
5	Synthesis of a Highly Azide-Reactive and Thermosensitive Biofunctional Reagent for Efficient Enrichment and Large-Scale Identification of O-GlcNAc Proteins by Mass Spectrometry. Anal Chem. 2017 Jun 6;89(11):5810-5817.
6	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
7	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
9	Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
10	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
11	Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012 Oct;11(10):1070-83.
12	Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J Proteome Res. 2010 Dec 3;9(12):6786-94.
13	Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
14	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
15	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
16	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
17	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
18	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
19	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
20	Proteome-Wide Analysis of Cysteine S-Sulfenylation Using a Benzothiazine-Based Probe. Curr Protoc Protein Sci. 2019 Feb;95(1):e76.
21	Redox proteomics of protein-bound methionine oxidation. Mol Cell Proteomics. 2011 May;10(5):M110.006866.
22	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
23	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
24	A COFRADIC protocol to study protein ubiquitination. J Proteome Res. 2014 Jun 6;13(6):3107-13.
25	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence